We are live on ! Find out more
NSPR icon

InspireMD

24 hedge funds and large institutions have $29.9M invested in InspireMD in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more capital invested

Capital invested by funds: $24M → $29.9M (+$5.89M)

4.5% more ownership

Funds ownership: 43.39%47.88% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

14% less funds holding

Funds holding: 2824 (-4)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
1
Increased
3
Reduced
3
Closed
4
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$46K
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
-$7.11K -3,000 Closed
Simplex Trading
27
Simplex Trading
Illinois
-$258 -110 Closed
Group One Trading
28
Group One Trading
Illinois
-$255 -109 Closed

NSPR Hedge Fund Activity: Q2 2024 in Review

24 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2024, worth a combined $29.9M — up 25% from $24M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NSPR and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Rosalind Advisors, adding an estimated $4.28M. The largest seller was Nantahala Capital Management, cutting an estimated $93.4K.

  • 24 institutional investors held InspireMD (NSPR) as of Q2 2024, down from 28 in Q1 2024.
  • Funds reported $29.9M of InspireMD stock for Q2 2024, up 25% quarter-over-quarter.
  • 1 fund opened new InspireMD positions in Q2 2024 and 4 closed out, a net change of -3 holders.
  • The largest InspireMD buyer in Q2 2024 was Rosalind Advisors, an estimated $4.28M added.
  • The largest InspireMD seller in Q2 2024 was Nantahala Capital Management, an estimated $93.4K sold.

Based on aggregated 13F filings for Q2 2024.